Sanoj Punnen, MD, MAS, presented “Integrating MRI and Molecular Markers to Detect Aggressive Prostate Cancer” during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019 in Boston, Massachusetts.

How to cite: Punnen, Sanoj. Integrating MRI and Molecular Markers to Detect Aggressive Prostate Cancer” October 3, 2019. Accessed May 2021. https://dev.grandroundsinurology.com/integrating-mri-and-molecular-markers-to-detect-aggressive-prostate-cancer/

Integrating MRI and Molecular Markers to Detect Aggressive Prostate Cancer – Summary:

Sanoj Punnen, MD, MAS, Associate Professor of Clinical Urology in the University of Miami Health System, describes how recent trial based research has supported the synergistic qualities of MRI and biomarkers in the cancer detection process by reducing unnecessary biopsies by approximately 25%. He notes that more research is needed to declare an ideal procedure as well as what biomarkers are most efficient. Introducing MRI reading AI by the name Habitat Risk Scoring System, he highlights his own research which could alter how MRIs are processed and increase NPV to 92% without the use of biopsy.

About The 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer:

The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a multi-day, multi-disciplinary forum designated to informing health care stakeholders about topics including in-vitro fluid- and tissue-based molecular diagnostics, novel observation strategies such as active surveillance, and novel therapeutic interventions. Along with this forum’s efforts to form a consensus on the future of prostate diagnostics and precision care, it aims to create an educational and research strategy for its realization. Dr. Punnen presented this lecture during the 4th iteration of this Summit in 2019.

For more educational content from this meeting, please visit our collection page.